(Q44122835)

English

Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 y

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 y (English)

1 reference

Europe PubMed Central

30 November 2017

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Linkeschova R

1

1 reference

Europe PubMed Central

30 November 2017

Raoul M

2

1 reference

Europe PubMed Central

30 November 2017

Bott U

3

1 reference

Europe PubMed Central

30 November 2017

Berger M

4

1 reference

Europe PubMed Central

30 November 2017

Spraul M

5

1 reference

Europe PubMed Central

30 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2002

1 reference

Europe PubMed Central

30 November 2017

Diabetic Medicine

1 reference

Europe PubMed Central

30 November 2017

19

1 reference

Europe PubMed Central

30 November 2017

9

1 reference

Europe PubMed Central

30 November 2017

746-751

1 reference

Europe PubMed Central

30 November 2017

Effect of patient-selected intensive insulin therapy on quality of life.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00713.X

21 January 2018

Continuous subcutaneous insulin infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self-selecting insulin-dependent diabetic patients. A comparison of metabolic control, acute complications and patient preferences

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00713.X

21 January 2018

Clinical use of the insulin infusion pump in 100 patients with type I diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00713.X

21 January 2018

Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00713.X

21 January 2018

Quality of life activities associated with adherence to insulin infusion pump therapy in the treatment of insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00713.X

21 January 2018

Evaluation of insulin pump treatment under routine conditions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00713.X

21 January 2018

Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00713.X

21 January 2018

Continuous subcutaneous insulin infusion versus injection therapy: a randomized cross-over trial under usual diabetic clinic conditions.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00713.X

21 January 2018

Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00713.X

21 January 2018

Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. A one-year prospective study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00713.X

21 January 2018

Complications and fetal outcome in diabetic pregnancy. Intensified conventional versus insulin pump therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00713.X

21 January 2018

Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00713.X

21 January 2018

Identifiers

10.1046/J.1464-5491.2002.00713.X

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44122835&oldid=2106817613"